Back to Search Start Over

Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?

Authors :
Montserrat, Emili
Dreger, Peter
Source :
Clinical Lymphoma, Myeloma & Leukemia; Aug2016 Supplement, Vol. 16, pS74-S81, 1p
Publication Year :
2016

Details

Language :
English
ISSN :
21522650
Volume :
16
Database :
Complementary Index
Journal :
Clinical Lymphoma, Myeloma & Leukemia
Publication Type :
Academic Journal
Accession number :
117336249
Full Text :
https://doi.org/10.1016/j.clml.2016.02.013